FDA approves Single-Site Instrumentation for Da Vinci Si Surgical System (Intuitive Surgical)

The FDA has given marketing approval for the Single-Site Instrumentation for the Da Vinci Si Surgical System, from Intuitive Surgical, for laparoscopic Cholecystectomy procedures, the surgical removal of the gall bladder. The da Vinci Surgical System is a surgical platform designed to enable complex surgery using a minimally invasive approach. It is commonly used for prostatectomies, and increasingly for cardiac valve repair and gynecologic surgical procedures. Single-Site Instrumentation provides da Vinci Si customers with a technology that enables Cholecystectomy via a single incision, while providing enhanced surgical precision, control and stability and 3D HD visualization. The Da Vinci Robotic surgery system was approved by the FDA in 2000.